Immunotherapies in Non-Hodgkin’s Lymphoma
Author:
Abstract
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
https://www.mdpi.com/2072-6694/13/14/3625/pdf
Reference47 articles.
1. Molecular and cellular genetics of non-Hodgkin lymphoma: Diagnostic and prognostic implications
2. Intravenous Infusion of Bone Marrow in Patients Receiving Radiation and Chemotherapy
3. IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
4. IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
5. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration;Cancer Medicine;2024-09
2. In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma;Medical Oncology;2023-12-28
3. Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS;Pathogens;2023-12-22
4. Multiagent Intratumoral Immunotherapy Can Be Effective in A20 Lymphoma Clearance and Generation of Systemic T Cell Immunity;Cancers;2023-03-24
5. Clinical advances in epigenetic therapies for lymphoma;Clinical Epigenetics;2023-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3